423 related articles for article (PubMed ID: 30717573)
1. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine.
Curto-Barredo L; Giménez-Arnau AM
G Ital Dermatol Venereol; 2019 Aug; 154(4):444-456. PubMed ID: 30717573
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
[TBL] [Abstract][Full Text] [Related]
3. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria.
Ayse Ornek S; Orcen C; Church MK; Kocaturk E
Int Immunopharmacol; 2022 Nov; 112():109198. PubMed ID: 36115277
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
[TBL] [Abstract][Full Text] [Related]
6. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease.
Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A
Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Strategy According to Differences in Response to Omalizumab in Patients With Chronic Spontaneous Urticaria.
Giménez Arnau AM; Valero Santiago A; Bartra Tomás J; Jáuregui Presa I; Labrador Horrillo M; Miquel Miquel FJ; Ortiz de Frutos J; Sastre J; Silvestre Salvador JF; Ferrer Puga M
J Investig Allergol Clin Immunol; 2019; 29(5):338-348. PubMed ID: 30222111
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.
Bérard F; Ferrier Le Bouedec MC; Bouillet L; Reguiai Z; Barbaud A; Cambazard F; Milpied B; Pelvet B; Kasujee I; Gharbi H; Lacour JP
Br J Dermatol; 2019 Jan; 180(1):56-66. PubMed ID: 29927483
[TBL] [Abstract][Full Text] [Related]
9. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
[TBL] [Abstract][Full Text] [Related]
10. Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.
Hon KL; Li JTS; Leung AKC; Lee VWY
Expert Opin Pharmacother; 2021 Mar; 22(4):497-509. PubMed ID: 32990110
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Pharmacologic Treatments for H1 Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Network Meta-analysis.
Nochaiwong S; Chuamanochan M; Ruengorn C; Awiphan R; Tovanabutra N; Chiewchanvit S
JAMA Dermatol; 2021 Nov; 157(11):1316-1327. PubMed ID: 34431983
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.
Saini SS; Bindslev-Jensen C; Maurer M; Grob JJ; Bülbül Baskan E; Bradley MS; Canvin J; Rahmaoui A; Georgiou P; Alpan O; Spector S; Rosén K
J Invest Dermatol; 2015 Jan; 135(1):67-75. PubMed ID: 25046337
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 is a potential player and treatment target in severe chronic spontaneous urticaria.
Sabag DA; Matanes L; Bejar J; Sheffer H; Barzilai A; Church MK; Toubi E; Maurer M; Vadasz Z
Clin Exp Allergy; 2020 Jul; 50(7):799-804. PubMed ID: 32412136
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence.
Metz M; Vadasz Z; Kocatürk E; Giménez-Arnau AM
Clin Rev Allergy Immunol; 2020 Aug; 59(1):38-45. PubMed ID: 32418171
[TBL] [Abstract][Full Text] [Related]
15. Safety of Methotrexate in Chronic Urticaria Unresponsive to Omalizumab.
Unsel M
Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):500-504. PubMed ID: 34418904
[TBL] [Abstract][Full Text] [Related]
16. An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria.
Altrichter S; Staubach P; Pasha M; Singh B; Chang AT; Bernstein JA; Rasmussen HS; Siebenhaar F; Maurer M
J Allergy Clin Immunol; 2022 May; 149(5):1683-1690.e7. PubMed ID: 34954198
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy.
Liao SL; Yu M; Zhao ZT; Maurer M
Front Immunol; 2021; 12():652973. PubMed ID: 33796115
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population.
Kulthanan K; Tuchinda P; Chularojanamontri L; Likitwattananurak C; Ungaksornpairote C
J Dermatolog Treat; 2017 Mar; 28(2):160-165. PubMed ID: 27388043
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis.
Rubini NPM; Ensina LFC; Silva EMK; Sano F; Solé D
Allergol Immunopathol (Madr); 2019; 47(6):515-522. PubMed ID: 31607407
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Hydroxychloroquine and Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study.
Khan N; Epstein TG; DuBuske I; Strobel M; Bernstein DI
J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3300-3305. PubMed ID: 36115542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
